Advertisement
Screener

Vaxart, Inc. (VXRT) Earnings Per Share (Diluted)

Vaxart, Inc. Earnings Per Share (Diluted)

Vaxart, Inc. (VXRT) reported Earnings Per Share (Diluted) of $0.02 per share for the 3-month period ending 2026-03-31, per its S-1 filed 2026-05-08.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:EarningsPerShareDiluted · last filed 2026-05-08

  • Vaxart, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was $0.02.
  • Vaxart, Inc. earnings per share, diluted for the quarter ending 2025-03-31 was -$0.07.
  • Vaxart, Inc. earnings per share, diluted for the quarter ending 2019-03-31 was -$0.18, a 136.73% decline year-over-year.
  • Vaxart, Inc. earnings per share, diluted for the quarter ending 2018-12-31 was -$0.69.
  • Vaxart, Inc. earnings per share, diluted for fiscal 2017 was -$0.76.
  • Vaxart, Inc. earnings per share, diluted for fiscal 2016 was -$0.66.
  • Vaxart, Inc. earnings per share, diluted for fiscal 2015 was -$0.54.
  • Vaxart, Inc. earnings per share, diluted for fiscal 2014 was -$0.35.
Period endEarnings Per Share, Diluted 3 monthEarnings Per Share, Diluted 3 month as first filedEarnings Per Share, Diluted 6 monthEarnings Per Share, Diluted 9 monthEarnings Per Share, Diluted 9 month as first filedEarnings Per Share, Diluted 12 monthEarnings Per Share, Diluted 12 month as first filed
2026-03-31$0.02
S-1 · filed 2026-05-08
2025-12-31$0.07
S-1 · filed 2026-05-08
2025-03-31-$0.07
S-1 · filed 2026-05-08
2024-12-31-$0.33
S-1 · filed 2026-05-08
2019-03-31-$0.18
10-Q · filed 2019-05-09
2018-12-31-$0.69
10-K · filed 2021-02-25
2018-09-30-$0.92
10-K · filed 2021-02-25
2018-06-30-$1.24
10-K · filed 2021-02-25
2018-03-31$0.49
10-K · filed 2021-02-25
2017-12-31-$0.09
10-Q · filed 2018-02-06
-$0.23
10-Q · filed 2018-02-06
2017-09-30-$0.14
10-Q · filed 2017-11-07
2017-06-30-$0.76
10-K · filed 2017-09-01
2017-03-31-$25.84
10-Q · filed 2018-05-15
-$0.11
10-Q · filed 2017-05-08
-$0.61
10-Q · filed 2017-05-08
2016-12-31-$0.24
10-Q · filed 2018-02-06
-$0.49
10-Q · filed 2018-02-06
2016-09-30-$0.26
10-Q · filed 2017-11-07
2016-06-30-$0.18
10-K · filed 2016-09-13
-$0.66
10-K · filed 2017-09-01
2016-03-31-$0.14
10-Q · filed 2017-05-08
-$0.48
10-Q · filed 2017-05-08
2015-12-31-$0.17
10-Q · filed 2017-02-06
-$0.34
10-Q · filed 2017-02-06
2015-09-30-$0.17
10-Q · filed 2016-11-08
2015-06-30-$0.55
10-K · filed 2016-09-13
-$0.54
10-K · filed 2016-09-13
2015-03-31$0.02
10-K · filed 2016-09-13
$0.03
10-Q · filed 2015-05-08
$0.02
10-Q · filed 2016-05-10
2014-12-31$0.19
10-K · filed 2016-09-13
-$0.01
10-Q · filed 2016-02-08
2014-09-30-$0.20
10-K · filed 2016-09-13
2014-06-30-$0.29
10-K · filed 2015-09-11
-$0.35
10-K · filed 2016-09-13
2014-03-31$0.09
10-K · filed 2015-09-11
-$0.03
10-Q · filed 2015-05-08
2013-12-31$0.00
10-K · filed 2015-09-11
-$0.14
10-Q · filed 2015-02-06
2013-09-30-$0.15
10-K · filed 2015-09-11
-$0.14
10-Q · filed 2013-11-12
2013-06-30-$0.23
10-K · filed 2014-09-30
-$0.32
10-K · filed 2015-09-11
-$0.31
10-K · filed 2013-09-27
2013-03-31$0.01
10-K · filed 2014-09-30
-$0.09
10-Q · filed 2014-05-12
-$0.08
10-Q · filed 2013-05-10
2012-12-31$0.16
10-K · filed 2014-09-30
$0.17
10-Q · filed 2013-02-11
-$0.09
10-Q · filed 2014-02-10
2012-09-30-$0.32
10-K · filed 2014-09-30
2012-06-30-$0.85
10-K · filed 2013-09-27
2012-03-31-$0.09
10-Q · filed 2013-05-10
-$0.59
10-Q · filed 2013-05-10
2011-12-31-$0.31
10-Q · filed 2013-02-11
-$0.50
10-Q · filed 2013-02-11
2011-06-30-$1.12
10-K · filed 2013-09-27
2011-06-25-$0.11
10-Q · filed 2011-08-03
-$0.06
10-Q · filed 2011-08-03
2010-06-26-$0.08
10-Q · filed 2011-08-03
$0.04
10-Q · filed 2011-08-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
BioStem Technologies, Inc. (BSEM)United States$0.069B
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
EXOZYMES INC. (EXOZ)United States$0.058B